(hereinafter referred to as "Chengdu Chipscreen Pharmaceutical"), established on April 28, 2014, is a wholly-owned subsidiary of Shenzhen Chipscreen Biosciences Co., Ltd. Chengdu Chipscreen Pharmaceutical is composed of two areas, namely, the "Innovative Drug Production Base" and the "Innovative Drug R&D Center and Regional Headquarters".
Innovative Drug Production Base：
located at No. 298 Kangqiang 1st Road, West High-tech Zone, Chengdu, covers an area of 100 mu (equivalent to about 66,667 square meters). Facilities here include oncology/non-oncology API workshops and oncology/non-oncology oral solid preparation workshops, which are designed in accordance with GMP standards published in the US, EU and China. In order to satisfy the needs for pilot scale tests of innovative drugs, preparation of clinical samples and production of marketed products, the construction of new facilities, such as pilot workshops for oncology/non-oncology APIs, multi-functional oral solid preparations and injections workshops, and antibody API manufacturing workshops, are under planning.
Innovative Drug R&D Center and Regional Headquarters：
located in Xinchuan Science and Technology Park, South High-tech Zone, cover an area of 25 mu (equivalent to 16,667 square meters). With the main body of the building already been roofed, this construction project is expected to be completed and put into use in 2020，which is expected to promote the product chain and give supports to clinical studies together with the Research & Early Development Center (Shenzhen) in a manner that they effectively complement each other in the research advantages. The Innovative Drug R&D Center and Regional Headquarters will play an important role in the R&D of the Group and make scientific and strategic contributions to the Group in the research and development of new drugs.